Table 2 Characteristics of patients with IBD
Crohn’s disease (n = 11) | Ulcerative colitis (n = 13) | |||
|---|---|---|---|---|
Montreal Classification Number of patients, n | Age at diagnosis (y) | Disease extent | ||
< 17 | 2 | Proctitis | 0 | |
17–40 | 6 | Left sided colitis | 7 | |
> 40 | 3 | Extensive colitis | 6 | |
Location | Disease severity | |||
Ileal | 7 | Clinical remission | 0 | |
Colonic | 2 | Mild | 0 | |
Ileocolonic | 2 | Moderate | 8 | |
Upper GI | 0 | Severe | 5 | |
Behavior | ||||
Non-stricturing, non-penetrating | 4 | |||
Stricturing | 5 | |||
Penetrating / fistulising | 2 | |||
Perianal | 1 | |||
Disease activity indices | Harvey Bradshaw Index (median, range) | 3 (0–8) | Simple Clinical Colitis Activity Index (median, range) | 2 (0–9) |
Medical therapy, Number of patients, n | Nil | 0 | 0 | |
5-ASAs only | 2 | 1 | ||
Steroids ±5-ASAs | 1 | 3 | ||
Azathioprine / 6-MP ± 5-ASAs / steroids | 1 | 3 | ||
Methotrexate ±5-ASAs / steroids | 0 | 1 | ||
IFX / ADA / vedolizumab ±5-ASAs / steroids | 2 | 2 | ||
IFX / ADA / vedolizumab ± immunomodulators | 5 | 3 | ||
Previous intestinal surgery / surgeries, Number of patients, n (%) | Jejunal resection | 0 | ||
Single ileo-colonic resection | 3 | 0 | ||
Multiple ileo-colonic resections | 1 | 0 | ||
Colectomy (total or subtotal) | 0 | 1 | ||